共 206 条
[1]
Subbarao P(2009)Asthma: epidemiology, etiology and risk factors CMAJ 181 E181-E190
[2]
Mandhane PJ(2010)The role of the T cell in asthma J Allergy Clin Immunol 126 1081-1091
[3]
Sears MR(2003)Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) J Thromb Haemost 1 1566-1574
[4]
Robinson DS(2010)What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse? J Thromb Haemost 8 868-876
[5]
Bouma BN(2006)Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis Arterioscler Thromb Vasc Biol 26 2445-2453
[6]
Meijers JC(2004)Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis Crit Care Med 32 S320-S324
[7]
Morser J(2001)Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma Am J Respir Crit Care Med 164 1841-1843
[8]
Gabazza EC(2000)Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma Nat Immunol 1 221-226
[9]
Myles T(2002)Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness Am J Respir Cell Mol Biol 27 413-418
[10]
Leung LL(2000)A role for the C3a anaphylatoxin receptor in the effector phase of asthma Nature 406 998-1001